Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (ELDN)

Historical Holders from Q4 2020 to Q3 2025

Symbol
ELDN on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
79,643,662
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
36,469,559
Holdings value
$94,453,818
% of all portfolios
0%
Number of holders
82
Number of buys
41
Number of sells
-44
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (ELDN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Coastlands Capital LP 5.98% $20,717,706 4,762,691 Matthew D. Perry 19 Nov 2025
VANGUARD GROUP INC 5.54% $8,992,818 3,318,383 The Vanguard Group 30 Jun 2025
BlackRock, Inc. 5.4% $8,815,386 3,252,910 BlackRock, Inc. 30 Jun 2025
ARMISTICE CAPITAL, LLC 4.99% $10,259,798 3,137,553 Armistice Capital, LLC 31 Dec 2024
Frazier Life Sciences Public Fund, L.P. 2% $3,847,923 1,176,735 James N. Topper 31 Dec 2024

Institutional Holders of Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (ELDN)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 36,469,559 $94,453,818 -$12,219,070 $2.59 82
2025 Q2 40,843,175 $110,685,079 +$5,557,133 $2.71 85
2025 Q1 38,448,901 $130,340,726 -$2,283,033 $3.39 83
2024 Q4 38,479,556 $158,542,263 +$81,995,653 $4.12 75
2024 Q3 18,485,827 $46,028,922 +$410,879 $2.49 33
2024 Q2 18,259,810 $48,206,187 +$22,892,459 $2.64 31
2024 Q1 9,595,061 $19,765,324 +$914,973 $2.06 28
2023 Q4 9,153,168 $16,475,058 +$507,102 $1.80 28
2023 Q3 8,917,722 $12,217,005 -$186,914 $1.37 28
2023 Q2 9,275,200 $12,707,758 +$2,932,975 $1.37 32
2023 Q1 6,240,661 $14,727,632 -$15,081 $2.36 29
2022 Q4 6,249,494 $14,377,182 -$299,603 $2.28 27
2022 Q3 6,267,437 $17,296,971 -$726,076 $2.76 26
2022 Q2 6,534,650 $15,944,119 -$1,242,145 $2.44 27
2022 Q1 7,004,967 $27,598,192 -$4,350,190 $3.94 30
2021 Q4 7,884,710 $34,745,775 -$3,532,209 $4.41 34
2021 Q3 8,434,281 $52,121,569 -$6,530,652 $6.18 29
2021 Q2 9,423,304 $74,527,000 +$5,445,356 $7.91 29
2021 Q1 8,317,680 $88,956,000 +$88,566,000 $10.70 32
2020 Q4 36,111 $556,000 +$556,000 $15.40 1